Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics Enters Clinical Collaboration With MSD

Dec 6 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * NYKODE THERAPEUTICS ANNOUNCES CLINICAL COLLABORATION WITH
MSD TO
EVALUATE VB10.16 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB)
IN PATIENTS WITH HPV16-POSITIVE HEAD AND NECK CANCER
    * UNDER TERMS OF AGREEMENT, MERCK WILL SUPPLY KEYTRUDA.
NYKODE
RETAINS ALL COMMERCIAL RIGHTS TO VB10.16 WORLDWIDE

Source text for Eikon:  ID:nObiBD6Hqa 
Further company coverage:  NYKD.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news